What we are studying
The purpose of this study is to compare the effects (both good and bad) of a blood thinning medication called rivaroxaban, to the effects of standard treatment at the hospital for patients who have a blood clot in their lung, called a pulmonary embolism (PE). Standard treatment follows the hospital’s current guidelines, which usually includes being admitted to the hospital and receiving medications that treat the blood clot in your lung. The medications that may be given as part of standard treatment for your PE are called anticoagulants, or blood thinners. This study is designed to show that it is safe to treat patients with a pulmonary embolism (PE) whose condition has a low risk of worsening, by taking rivaroxaban at home without being admitted to the hospital.
Participants will receive $58.00 for each in person study visit to help with expenses like travel and parking expenses.